(1)
Pınar, İbrahim E.; Ozkocaman, V. Efficacy and Safety Outcomes of Single-Agent Ibrutinib Therapy in Chronic Lymphocytic Leukemia and Relapsed Refractory Mantle-Cell Lymphoma. Eur Res J 2023, 9 (6), 1483-1492. https://doi.org/10.18621/eurj.1359362.